Jump to:
Abingdon Health PLC Fundamentals
| Company Name | Abingdon Health PLC | Last Updated | 2025-12-11 |
|---|
| Industry | Diagnostics & Research | Sector | Healthcare |
|---|
| Shares in Issue | 251.073 m | Market Cap | £17.19 m |
|---|
| PE Ratio | 0.00 | Dividend per Share | 0 |
|---|
| Dividend Yield | 0 | Dividend Cover | 0 |
|---|
| EPS | -£0.01 | EPS Growth (%) | 0 |
|---|
| PEG | 0 | DPS Growth (%) | 0 |
|---|
| Debt Ratio | 0.1104 | Debt Equity Ratio | 0.1447 |
|---|
| Asset Equity Ratio | 1.7572 | Cash Equity Ratio | 0.3619 |
|---|
| Quick Ratio | 1.4430 | Current Ratio | 1.76 |
|---|
| Price To Book Value | 3.1980 | ROCE | 0 |
|---|
Abingdon Health PLC Dividends
| Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
|---|
Abingdon Health PLC Company Financials
| Assets | 2025 | 2024 | 2023 | 2022 |
|---|
| Tangible Assets | £1.04 m | £997,000.00 | £1.26 m | £1.84 m |
| Intangible Assets | £2.79 m | £532,000.00 | £90,000.00 | £36,000.00 |
| Investments | £354,000.00 | £13,000.00 | 0 | 0 |
| Total Fixed Assets | £4.18 m | £1.54 m | £1.35 m | £1.88 m |
| Stocks | £526,000.00 | £441,000.00 | £329,000.00 | £534,000.00 |
| Debtors | £2.29 m | £1.44 m | £1.10 m | £7.84 m |
| Cash & Equivalents | £1.92 m | £1.44 m | £3.24 m | £2.40 m |
| Other Assets | 0 | 0 | 0 | 0 |
| Total Assets | £9.31 m | £5.09 m | £6.11 m | £12.83 m |
| Liabilities | 2025 | 2024 | 2023 | 2022 |
|---|
| Creditors within 1 year | £2.92 m | £1.82 m | £2.12 m | £5.32 m |
| Creditors after 1 year | £1.09 m | £1.02 m | £1.02 m | £1.10 m |
| Other Liabilities | 0 | 0 | 0 | 0 |
| Total Liabilities | £4.01 m | £2.84 m | £3.14 m | £6.42 m |
| Net assets | £5.30 m | £2.25 m | £2.97 m | £6.41 m |
| Equity | 2025 | 2024 | 2023 | 2022 |
|---|
| Called up share capital | £49,000.00 | £32,000.00 | £31,000.00 | £76,000.00 |
| Share Premium | £37.04 m | £30.81 m | £30.31 m | £30.31 m |
| Profit / Loss | -£3.50 m | -£1.40 m | -£3.57 m | -£21.59 m |
| Other Equity | £5.30 m | £2.25 m | £2.97 m | £6.41 m |
| Preference & Minorities | 0 | 0 | 0 | 0 |
| Total Capital Employed | £5.30 m | £2.25 m | £2.97 m | £6.41 m |
| Ratios | 2025 | 2024 | 2023 | 2022 |
|---|
| Debt Ratio | £0.13 | £0.29 | £0.24 | £0.14 |
| Debt-to-Equity | £0.14 | £0.41 | £0.31 | £0.16 |
| Assets / Equity | 1.7572 | 1.7572 | 1.7572 | 1.7572 |
| Cash / Equity | 0.3619 | 0.3619 | 0.3619 | 0.3619 |
| EPS | -£0.01 | £-0.00 | -£0.01 | -£0.04 |
| Cash Flow | 2025 | 2024 | 2023 | 2022 |
|---|
| Cash from operating activities | -£3.18 m | -£1.66 m | £913,000.00 | -£7.74 m |
| Cashflow before financing | £1.90 m | -£1.77 m | £906,000.00 | -£1.82 m |
| Increase in Cash | £474,000.00 | -£1.80 m | £839,000.00 | -£2.58 m |
| Income | 2025 | 2024 | 2023 | 2022 |
|---|
| Turnover | £8.43 m | £6.13 m | £4.04 m | £2.83 m |
| Cost of sales | £4.69 m | £2.46 m | £1.97 m | £6.43 m |
| Gross Profit | £3.74 m | £3.68 m | £2.08 m | -£3.59 m |
| Operating Profit | -£3.51 m | -£1.37 m | -£3.59 m | -£21.53 m |
| Pre-Tax profit | -£3.50 m | -£1.40 m | -£3.57 m | -£21.59 m |
Abingdon Health PLC Company Background
| Sector | Healthcare |
|---|
| Activities | Abingdon Health PLC develops, manufactures, and distributes diagnostic devices and provides regulatory consultancy to diagnostics businesses. It offers integrated lateral flow CRO/CDMO services covering feasibility, manufacturing, packaging, kitting, documentation, and commercial support. Segments include Contract Development (milestone-based third-party work, revenue over time by completion), Contract Manufacturing (development/manufacturing via daily consultancy, revenue at customer control point), Product Sales (AbC-19TM, Pocket Diagnostic, PCRD tests, research antibodies, carriage; point in time), and Regulatory Services (IVD/medical device compliance, revenue over time), with key revenue from Regulatory Services. It operates in the UK, USA/Canada, Europe, and rest of world. |
|---|
| Latest Interim Date | 24 Mar 2025 |
|---|
| Latest Fiscal Year End Date | 11 Nov 2025 |
|---|
Abingdon Health PLC Directors
| Appointed | Name | Position |
|---|
| 2025-05-02 | Mr. Thomas Edward Hayes | Executive Director,Chief Financial Officer |
| 2025-11-14 | Dr. Christopher William Hand | Executive Director,Chairman |
| 2025-08-14 | Mr. Chris Henry Francis Yates | Executive Director,Chief Executive Officer |
| 2024-10-08 | Ms. Melanie Ross | Executive Director,Chief Financial Officer and Company Secretary |
| 2021-11-29 | Mr. Scott Andrew Page | Company Secretary |
Abingdon Health PLC Contact Details
Abingdon Health PLC Advisors
